Companies working on next-generation drug therapies for hepatitis B have been talking about achieving a “functional cure” of the virus for several years now, but as candidates progress through the pipeline, consensus seems to be emerging about the best way to accomplish this.
“Functional cure” – meaning treating HBV with a temporary and largely curative regimen, similar to the drug cocktails used in...